Found: 9
Select item for more details and to access through your institution.
Effects of somatostatin receptor type 2 antagonism during insulin‐induced hypoglycaemia in male rats with prediabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1547, doi. 10.1111/dom.15002
- By:
- Publication type:
- Article
ZT‐01: A novel somatostatin receptor 2 antagonist for restoring the glucagon response to hypoglycaemia in type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 5, p. 908, doi. 10.1111/dom.14652
- By:
- Publication type:
- Article
Somatostatin Receptor Antagonism Reverses Glucagon Counterregulatory Failure in Recurrently Hypoglycemic Male Rats.
- Published in:
- Endocrinology, 2021, v. 162, n. 12, p. 1, doi. 10.1210/endocr/bqab189
- By:
- Publication type:
- Article
Hyperglycaemia correlates with skeletal muscle capillary regression and is associated with alterations in the murine double minute-2/forkhead box O1/thrombospondin-1 pathway in type 1 diabetic BioBreeding rats.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 6, n. 1, p. 28, doi. 10.1177/1479164118805928
- By:
- Publication type:
- Article
Phosphorylation of murine double minute-2 on Ser<sup>166</sup> is downstream of VEGF-A in exercised skeletal muscle and regulates primary endothelial cell migration and FoxO gene expression.
- Published in:
- FASEB Journal, 2016, v. 30, n. 3, p. 1120, doi. 10.1096/fj.15-276964
- By:
- Publication type:
- Article
Evaluating the effectiveness of a novel somatostatin receptor 2 antagonist, ZT-01, for hypoglycemia prevention in a rodent model of type 2 diabetes.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1302015
- By:
- Publication type:
- Article
133-OR: Somatostatin Receptor Type 2 Antagonism (SSTR2a) Augments Glucagon Counterregulation and Delays Hypoglycemia Onset in Type 2 Diabetic (T2D), Sprague-Dawley Rats.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-133-OR
- By:
- Publication type:
- Article
9-LB: Novel Somatostatin Receptor 2 Antagonist ZT-01 Prevents Hypoglycemia Onset in STZ-Diabetic Rats by Improving Glucagon Secretion.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-9-LB
- By:
- Publication type:
- Article
14-LB: Somatostatin Receptor 2 Antagonism Enhances Plasma Glucagon Levels during Insulin-Induced Hypoglycemia in a Rodent Model of Type 2 Diabetes Mellitus.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-14-LB
- By:
- Publication type:
- Article